Renflexis

Active Ingredient(s): Infliximab-abda
FDA Approved: * April 21, 2017
Pharm Company: * SAMSUNG BIOEPSIS CO LTD
Category: Immunosuppressive

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Renflexis Overview

Infliximab (trade names Remicade among others) is a chimeric monoclonal antibody biologic drug that works against tumor necrosis factor alpha (TNF-α) and is used to treat autoimmune diseases. Infliximab was approved by the U.S. Food and Drug Administration (FDA) for the treatment of Crohn's disease, ulcerative colitis, psoriasis, psoriatic arthritis, ankylosing spondylitis, and rheumatoid arthritis.[1] It is used off-label outside its FDA approval for Behçet's diseas...

Read more Renflexis Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Infliximab

Recent Renflexis Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

NDC Database Records for Renflexis: (1 result)

Sorted by National Drug Code

• 0006-4305 Renflexis 100 mg Intravenous Injection, Powder, Lyophilized, for Solution by Merck Sharp & Dohme Corp.

Other drugs which contain Infliximab-abda or a similar ingredient: (4 results)

• INFLECTRA Infliximab-dyyb
• INFLIXIMAB 2 discussions
• INFLIXIMAB-ABDA
• REMICADE Infliximab20 discussions